Skip to main content
. 2020 Jul 3;24(2):87–95. doi: 10.5114/wo.2020.97520

Fig. 2.

Fig. 2

Cytoplasmic expression of ITM2A: (A) high expression in intra-ducal carcinoma ×400, (B) high expression in low-grade triple- negative breast cancer TNBC stage II ×400, (C) low expression in high-grade triple-negative breast cancer TNBC, stage IV ×400